Crossmark

Seroprevalence of hepatitis B among the general population in Shandong Province, Eastern China, an update 30 years after the implementation of the neonatal vaccination program

Crossref DOI link: https://doi.org/10.1186/s12879-024-10340-0

Published Online: 2024-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Bingyu

Zhang, Xiaomeng

Lv, Jingjing

Feng, Yi

Meng, Xin

Lin, Xiaojuan

Zhang, Yan

Wang, Suting

Ji, Feng

Chen, Meng

Yuan, Xinyu

Tao, Zexin

Zhang, Li
Funding

Funding for this research was provided by:

Taishan Scholar Project of Shandong Province (tstp20221164)
License Information

Text and Data Mining valid from 2024-12-18

Version of Record valid from 2024-12-18
More Information

Article History

Received: 27 August 2024

Accepted: 11 December 2024

First Online: 18 December 2024

Declarations

:

: The survey was approved by the Ethics Committee of the China CDC. The informed consent was obtained from all participants, or their parents or legal guardians if the participants were under the age of 18. The use of the remaining samples to test for serologic indicators of hepatitis B was approved by the Shandong CDC Ethics Committee (SDJK-2023-012-01).

: All participants consented to the publication of this manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below